1
|
Luhana M, Karim J. The Adult Epiglottitis Enigma: A Case Report. Cureus 2023; 15:e49984. [PMID: 38179346 PMCID: PMC10766345 DOI: 10.7759/cureus.49984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/05/2023] [Indexed: 01/06/2024] Open
Abstract
Adult epiglottitis, once primarily associated with pediatric populations, has emerged as a distinctive clinical entity with potentially life-threatening implications. This condition is characterized by inflammation and swelling of the epiglottis, presenting initially as a seemingly benign sore throat and dysphagia but progressing rapidly to more severe symptoms such as drooling, severe odynophagia, hoarse voice, and acute upper airway obstruction. Timely diagnosis and intervention are paramount, as delayed presentation can result in fatal outcomes even in adults. The cornerstone of treatment involves securing the airway, providing supplemental oxygen, and administering intravenous antibiotics. In this report, we present a case of adult epiglottitis in a 20-year-old individual, discussing the clinical presentation, diagnostic considerations, and the essential components of its management. Recognition of adult epiglottitis as a distinct clinical entity is crucial for healthcare practitioners to ensure prompt intervention and optimize patient outcomes.
Collapse
Affiliation(s)
- Mitanshi Luhana
- Otolaryngology - Head and Neck Surgery, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, GBR
| | - Jumana Karim
- General Surgery, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, GBR
| |
Collapse
|
2
|
Kaiser RM, Cash-Goldwasser S, Lehnertz N, Griffith J, Ruprecht A, Stanton J, Feldpausch A, Pavlick J, Bruen CA, Perez-Molinar D, Peglow SR, Akinsete OO, Morris SB, Raizes E, Gregory C, Lynfield R. Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022. Emerg Infect Dis 2023; 29:1855-1858. [PMID: 37437558 PMCID: PMC10461671 DOI: 10.3201/eid2909.230469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/14/2023] Open
Abstract
We report 2 cases of pharyngeal monkeypox virus and group A Streptococcus co-infection in the United States. No rash was observed when pharyngitis symptoms began. One patient required intubation before mpox was diagnosed. Healthcare providers should be aware of oropharyngeal mpox manifestations and possible co-infections; early treatment might prevent serious complications.
Collapse
Affiliation(s)
| | | | - Nicholas Lehnertz
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Jayne Griffith
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Alison Ruprecht
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - John Stanton
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Amanda Feldpausch
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Jessica Pavlick
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Charles A. Bruen
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - David Perez-Molinar
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - S. Rebecca Peglow
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Omobosola O. Akinsete
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Sapna Bamrah Morris
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Elliot Raizes
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Christopher Gregory
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| | - Ruth Lynfield
- HealthPartners Regions Hospital, Saint Paul, Minnesota, USA (R.M. Kaiser, C.A. Bruen, D. Perez-Molinar, S.R. Peglow, O.O. Akinsete)
- Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Cash-Goldwasser, S. Bamrah Morris, E. Raizes, C. Gregory)
- Minnesota Department of Health, Saint Paul (N. Lehnertz, J. Griffith, A. Ruprecht, R. Lynfield)
- Positive Impact Health Centers, Decatur, Georgia, USA (J. Stanton)
- Emory University, Atlanta (J. Stanton)
- Georgia Department of Public Health, Atlanta (A. Feldpausch, J. Pavlick)
| |
Collapse
|
3
|
Kimura Y, Jo T, Inoue N, Suzukawa M, Tanaka G, Kage H, Kumazawa R, Matsui H, Fushimi K, Yasunaga H, Matsui H. Association Between Systemic Corticosteroid Use and Mortality in Patients with Epiglottitis. Laryngoscope 2023; 133:344-349. [PMID: 35305022 DOI: 10.1002/lary.30110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Accepted: 03/10/2022] [Indexed: 01/19/2023]
Abstract
OBJECTIVES To clarify whether treatment with systemic corticosteroids at a certain dose was associated with better outcomes in patients with epiglottitis requiring airway management (tracheotomy or airway intubation). METHODS This was a retrospective cohort study on patients hospitalized for epiglottitis requiring airway management from a nationwide inpatient database (between July 2010 and March 2019). Patients treated with systemic corticosteroids equivalent to methylprednisolone ≥40 mg/d within 2 days of admission and patients who were not treated with corticosteroids within 2 days of admission were compared after inverse probability of treatment weighting using covariate balancing propensity score. The primary outcome was all-cause 30-day in-hospital mortality, and secondary outcomes included all-cause 7-day in-hospital mortality, length of hospital stay, and total medical cost. RESULTS There were 1986 and 1771 patients in the corticosteroid and control groups, respectively. A total of 72 of 3757 (1.9%) patients died within 30 days of admission, including 17 of 1986 (0.9%) patients in the corticosteroid group and 55 of 1771 (3.1%) in the control group (weighted odds ratio, 0.28 [95% confidence interval, 0.11-0.70]; weighted risk difference, -2.2% [-3.2% to -1.3%]). Treatment with corticosteroids was associated with lower total medical costs (weighted median, $6,187 vs. $6,587; weighted difference, $-1,123 [-2,238 to -8]) but not all-cause 7-day in-hospital mortality (weighted odds ratio, 0.63 [0.22-1.82]; weighted risk difference, -0.3% [-0.9 to 0.2]) and length of hospital stay (weighted median, 13 vs. 13 days; weighted difference, -0.2 days [-2.1 to 1.8]). CONCLUSIONS Systemic corticosteroids may be beneficial to patients with epiglottitis requiring airway management. LEVEL OF EVIDENCE 3 Laryngoscope, 133:344-349, 2023.
Collapse
Affiliation(s)
- Yuya Kimura
- Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Tokyo, Japan
| | - Taisuke Jo
- Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.,Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Norihiko Inoue
- Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.,Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Tokyo, Japan
| | - Maho Suzukawa
- Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Tokyo, Japan
| | - Goh Tanaka
- Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Hidenori Kage
- Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Ryosuke Kumazawa
- Department of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Hiroki Matsui
- Department of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Kiyohide Fushimi
- Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School, Tokyo, Japan.,Department of Clinical Data Management and Research, Clinical Research Center, National Hospital Organization Headquarters, Tokyo, Japan
| | - Hideo Yasunaga
- Department of Clinical Epidemiology and Health Economics, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
| | - Hirotoshi Matsui
- Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, Tokyo, Japan
| |
Collapse
|
4
|
A Network Meta-analysis of Dexamethasone for Preventing Postextubation Upper Airway Obstruction in Children. Ann Am Thorac Soc 2023; 20:118-130. [PMID: 35976878 PMCID: PMC9819263 DOI: 10.1513/annalsats.202203-212oc] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Rationale: Periextubation corticosteroids are commonly used in children to prevent upper airway obstruction (UAO). However, the best timing and dose combination of corticosteroids is unknown. Objectives: To compare effectiveness of different corticosteroid regimens in preventing UAO and reintubation. Methods: MEDLINE, CINAHL, and Embase search identified randomized trials in children using corticosteroids to prevent UAO. All studies used dexamethasone. The studies were categorized based on timing of initiation of dexamethasone (early use: >12 h before extubation) and the dose (high dose: ⩾0.5 mg/kg/dose). We performed Bayesian network meta-analysis with studies grouped into four regimens: high dose, early use (HE); low dose, early use (LE); high dose, late use (HL); and low dose, late use. Results: Eight trials (n = 903) were included in the analysis. For preventing UAO (odds ratio; 95% credible interval), HE (0.13; 0.04-0.36), HL (0.39; 0.19-0.74), and LE (0.15; 0.04-0.58) regimens appear to be more effective than no dexamethasone (low certainty). HE and LE had the highest probability of being the top-ranked regimens for preventing UAO (surface under the cumulative ranking curve 0.901 and 0.808, respectively). For preventing reintubation, the effect estimate was imprecise for all four dexamethasone regimens compared with no dexamethasone (very low certainty). HE and LE were the top-ranked regimens (surface under the cumulative ranking curve 0.803 and 0.720, respectively) for preventing reintubation. Sensitivity analysis showed that regimens that started >12 hours before extubation were likely more effective than regimens started >6 hours before extubation. Conclusions: Periextubation dexamethasone can prevent postextubation UAO in children, but effectiveness is highly dependent on timing and dosing regimen. Early initiation (ideally >12 h before extubation) appears to be more important than the dose of dexamethasone. Ultimately, the specific steroid strategy should be personalized, considering the potential for adverse events associated with dexamethasone and the individual risk of UAO and reintubation.
Collapse
|
5
|
Preoperative Dexamethasone for Airway-Related "Calibration Tube" Complications After Sleeve Gastrectomy: a Randomised Clinical Trial. Obes Surg 2021; 31:4790-4798. [PMID: 34324100 DOI: 10.1007/s11695-021-05619-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2021] [Revised: 07/16/2021] [Accepted: 07/20/2021] [Indexed: 10/20/2022]
Abstract
BACKGROUND Bariatric surgeries utilise Bougie device to guide stomach resection. The device implementation is associated with many underreported complications. This study aims to compare nebulised vs. intravenous preoperative dexamethasone in mitigating airway-related Bougie complications after sleeve gastrectomy. METHODOLOGY This is a prospective double-blinded interventional study conducted by a tertiary hospital. The study involved 105 patients allocated to 3 groups: Group (I) received 8 mg dexamethasone intravenously (IV) preoperatively, group (N) received 8 mg dexamethasone from a nebulizer mask preoperatively, and Group (S) received nebulised normal saline. Outcomes evaluated were postoperative sore throat, odynophagia, change of voice, and nausea and vomiting. RESULTS Nebulized dexamethasone was found to be significantly superior to IV dexamethasone in terms of postoperative sore throat at zero-hour (p = 0.001) and 1-h intervals (p = 0.011). No significant difference was found at 6- and 24-h intervals. For odynophagia, post hoc analysis showed there was no significant difference between (I), (N), and (S) groups. Incidence of change of voice was significantly lower in (N) and (I) groups compared to (S) group, with p values of 0.0067 and 0.00014, respectively. The incidence of post-operative sore-throat (PONV) in (I) group was significantly lower than incidences in (S) group (p = 0.00002) and (N) group (p = 0.0004). CONCLUSION Preoperative nebulized and IV dexamethasone are effective strategies in mitigating complications related to mechanical effects of Bougie insertion. IV dexamethasone was as effective as nebulized dexamethasone in terms of late postoperative sore throat, and was superior in postoperative nausea and vomiting.
Collapse
|
6
|
Khalid N, Bilal M, Umer M. Non-Traumatic Laryngeal Fractures: A Systematic Review. Turk Arch Otorhinolaryngol 2021; 59:65-75. [PMID: 33912863 PMCID: PMC8054934 DOI: 10.4274/tao.2020.6093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2020] [Accepted: 12/27/2020] [Indexed: 12/01/2022] Open
Abstract
Non-traumatic laryngeal fractures are an extremely uncommon presentation, and the diagnosis can be missed. Recognizing these fractures is important to appropriately direct management because most have a good prognosis and result in complete recovery. This article aimed to review the characteristics of all documented cases of non-traumatic fractures of the larynx. We sought to address questions related to the etiology, clinical presentation, and diagnostic assessment of this condition and provide recommendations about the management of these fractures. Electronic databases, mainly PubMed and Google Scholar, were searched for relevant literature with no language or time restrictions. Since 1950, 15 cases of non-traumatic laryngeal fractures have been documented in the medical literature. Out of these, thyroid cartilage fractures have been described in 14 patients, while only one instance demonstrated a fracture in the cricoid cartilage. Patients were managed conservatively using voice rest and observation with complete recovery in all cases. All patients who present with odynophagia, hoarseness, and tenderness over the thyroid cartilage after an episode of severe coughing or sneezing, should be evaluated for a thyroid cartilage fracture using laryngoscopy and computed tomography scan. Management of the airway should be the primary priority in any laryngeal injury, and further management performed after the airway is stable.
Collapse
Affiliation(s)
- Noor Khalid
- Department of Otorhinolaryngology, Rawalpindi Medical University, Rawalpindi, Pakistan
| | - Muhammad Bilal
- Department of Otorhinolaryngology, Foundation University Medical College, Islamabad, Pakistan
| | - Muhammad Umer
- Department of Otorhinolaryngology, Army Medical College, Rawalpindi, Pakistan
| |
Collapse
|
7
|
Abbasi S, Emami Nejad A, Kashefi P, Ali Kiaei B. Comparison of Nebulized Budesonide and Intravenous Dexamethasone Efficacy on Tracheal Tube Cuff Leak in Intubated Patients admitted to Intensive Care Unit. Adv Biomed Res 2018; 7:154. [PMID: 30662883 PMCID: PMC6319034 DOI: 10.4103/abr.abr_148_18] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Background: Tracheal intubation is a common action in intensive care unit (ICU); however, it may cause laryngeal edema or laryngotracheal injury which leads to edema. The cuff-leak test is usually done to define the upper airway patency. Considering the point that laryngeal edema would be treated by anti-inflammatory agents, our aim was to evaluate the impact of nebulized budesonide on ICU patients’ relief and comparison between nebulized budesonide efficacy and intravenous (IV) dexamethasone. Materials and Methods: In our clinical trial, 270 intubated patients from ICU were randomly selected and divided into three groups (each group was included 90 patients) as follows: IV dexamethasone, nebulized budesonide, and placebo group. All the patients were monitored at 0, 12, 24, 36, and 48 h of starting follow-up. Hemodynamic parameters and cuff-leak ratio were measured and data were analyzed using SPSS (ver. 20). Results: Our findings revealed that dexamethasone and budesonide treatment approaches were beneficial for an increase of cuff-leak volume (P < 0.001). Furthermore, the superiority of mentioned methods in patients’ relief was significant compared with placebo group (P < 0.001). Moreover, hemodynamic parameters were not altered and were within the normal range in both dexamethasone and budesonide groups (P > 0.05). Conclusion: Our findings demonstrated that the use of budesonide and dexamethasone is beneficial in intubated ICU patients, and the above-mentioned approaches can reduce the complications of tracheal intubation. Furthermore, budesonide could be a trustworthy substitute treatment strategy instead of IV dexamethasone.
Collapse
Affiliation(s)
- Saeed Abbasi
- Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Abbas Emami Nejad
- Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Parviz Kashefi
- Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Babak Ali Kiaei
- Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| |
Collapse
|
8
|
McDonald C, Hennedige A, Henry A, Dawoud B, Kulkarni R, Gilbert K, Kyzas P, Morrison R, McCaul J. Management of cervicofacial infections: a survey of current practice in maxillofacial units in the UK. Br J Oral Maxillofac Surg 2017; 55:940-945. [DOI: 10.1016/j.bjoms.2017.09.002] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2017] [Accepted: 09/07/2017] [Indexed: 11/28/2022]
|
9
|
Cho DY, Sinha SR, Gardner JM, Schaller MP, Pamnani RD, Felt SA, Barral JK, Messner AH. Effect of intratonsillar injection of steroids on the palatine tonsils of rabbits. Laryngoscope 2013; 124:2811-7. [PMID: 24114886 DOI: 10.1002/lary.24396] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 07/28/2013] [Accepted: 08/19/2013] [Indexed: 11/07/2022]
Abstract
OBJECTIVES/HYPOTHESIS Nasal steroids may significantly improve nasal obstructive symptoms with a reduction of adenoid size in children, but they do not consistently yield the same concurrent effect on enlarged palatine tonsils. Failure of nasal steroids to decrease the size of palatine tonsils is believed to be attributable to location and washout by saliva. The purpose of this study was to determine if direct application of steroid via intratonsillar injection would reduce the size of palatine tonsils in the rabbit model. STUDY DESIGN Prospective animal study. METHODS Eight rabbits (16 tonsils) were administered intratonsillar injections of fluticasone (n = 8, 1 mg/ml) or saline (n = 8, 0.1 ml) on days 0, 3, 7, 10, 14, and 17. Two rabbits (4 tonsils) received a single steroid injection to compare single versus multiple steroid injections. The rabbit's tonsil size was measured before each injection. After the fifty injections, the tonsils were harvested for histologic analysis. RESULTS A total of 16 tonsils were analyzed. After five steroid injections, the reduction (-7.7 mm(2) ± 4.27) in size was statistically significant when compared to reduction (6.12 mm(2) ± 6.57) in the saline injected group (P = 0.001). Repeated steroid injection was more potent than a single injection (-3.00 mm(2) ± 3.08) in reducing the size (P = 0.006). In histologic analysis, tonsils after repeated steroid injections were significantly smaller than saline-injected tonsils (P = 0.014), without obvious lymphoid follicles. CONCLUSION Repeated focal tonsillar injections of corticosteroids significantly reduced the size of palatine tonsils as compared to saline-injected controls. A single injection of corticosteroids appears to be effective, but not as effective, as multiple injections. LEVEL OF EVIDENCE N/A.
Collapse
Affiliation(s)
- Do-Yeon Cho
- Department of Otolaryngology-Head and Neck Surgery, Stanford University, School of Medicine, Stanford, California
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Wittekamp BHJ, van Mook WNKA, Tjan DHT, Zwaveling JH, Bergmans DCJJ. Clinical review: post-extubation laryngeal edema and extubation failure in critically ill adult patients. CRITICAL CARE : THE OFFICIAL JOURNAL OF THE CRITICAL CARE FORUM 2009; 13:233. [PMID: 20017891 PMCID: PMC2811912 DOI: 10.1186/cc8142] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Laryngeal edema is a frequent complication of intubation. It often presents shortly after extubation as post-extubation stridor and results from damage to the mucosa of the larynx. Mucosal damage is caused by pressure and ischemia resulting in an inflammatory response. Laryngeal edema may compromise the airway necessitating reintubation. Several studies show that a positive cuff leak test combined with the presence of risk factors can identify patients with increased risk for laryngeal edema. Meta-analyses show that pre-emptive administration of a multiple-dose regimen of glucocorticosteroids can reduce the incidence of laryngeal edema and subsequent reintubation. If post-extubation edema occurs this may necessitate medical intervention. Parenteral administration of corticosteroids, epinephrine nebulization and inhalation of a helium/oxygen mixture are potentially effective, although this has not been confirmed by randomized controlled trials. The use of non-invasive positive pressure ventilation is not indicated since this will delay reintubation. Reintubation should be considered early after onset of laryngeal edema to adequately secure an airway. Reintubation leads to increased cost, morbidity and mortality.
Collapse
Affiliation(s)
- Bastiaan H J Wittekamp
- Department of Intensive Care, Gelderse Vallei Hospital, Willy Brandtlaan 10, 6716 RP Ede, The Netherlands.
| | | | | | | | | |
Collapse
|
11
|
Park SH, Han SH, Do SH, Kim JW, Rhee KY, Kim JH. Prophylactic Dexamethasone Decreases the Incidence of Sore Throat and Hoarseness After Tracheal Extubation with a Double-Lumen Endobronchial Tube. Anesth Analg 2008; 107:1814-8. [DOI: 10.1213/ane.0b013e318185d093] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
12
|
Sittel C. [Adjuvants in operative laryngology: corticosteroids, fibrin adhesives, Mitomycin C]. HNO 2008; 56:1175-82. [PMID: 19020847 DOI: 10.1007/s00106-008-1724-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Medicinal adjuvants are often used in operative laryngology but their value is judged very differently. The scientific evidence is unsatisfactory for most of these substances. For corticosteroids it is proven that in pediatric intensive care they reduce stridor following extubation. Routine prophylactic use for intubation does not seem to be justified and methylprednisolone and dexamethasone are the preferred preparations. Fibrin adhesives are well tolerated and low in side-effects. The indications for their use should be primarily limited due to the cost factor. Their use in laryngology remains a decision on an individual case-to-case basis. Mitomycin C is used because of its antiproliferative effect on fibroblasts in order to reduce scar tissue formation. Many positive effects have been attributed to the topical application but there are large differences in dosage and exposure time.
Collapse
Affiliation(s)
- C Sittel
- Klinik für Hals-, Nasen-, Ohrenkrankheiten, Plastische Operationen, Klinikum Stuttgart - Katharinenhospital, Stuttgart, Germany.
| |
Collapse
|
13
|
Fan T, Wang G, Mao B, Xiong Z, Zhang Y, Liu X, Wang L, Yang S. Prophylactic administration of parenteral steroids for preventing airway complications after extubation in adults: meta-analysis of randomised placebo controlled trials. BMJ 2008; 337:a1841. [PMID: 18936064 PMCID: PMC2570741 DOI: 10.1136/bmj.a1841] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
OBJECTIVE To determine whether steroids are effective in preventing laryngeal oedema after extubation and reducing the need for subsequent reintubation in critically ill adults. DESIGN Meta-analysis. DATA SOURCES PubMed, Cochrane Controlled Trials Register, Web of Science, and Embase with no limitation on language, study year, or publication status. Selection criteria Randomised placebo controlled trials in which parenteral steroids were compared with placebo for preventing complications after extubation in adults. Review methods Search, application of inclusion and exclusion criteria, data extraction, and assessment of methodological quality, independently performed in duplicate. Odds ratios with 95% confidence intervals, risk difference, and number needed to treat were calculated and pooled. PRIMARY OUTCOME laryngeal oedema after extubation. Secondary outcome: subsequent reintubation because of laryngeal oedema. RESULTS Six trials (n=1923) were identified. Compared with placebo, steroids given before planned extubation decreased the odds ratio for laryngeal oedema (0.38, 95% confidence interval 0.17 to 0.85) and subsequent reintubation (0.29, 0.15 to 0.58), corresponding with a risk difference of -0.10 (-0.12 to -0.07; number needed to treat 10) and -0.02 (-0.04 to -0.01; 50), respectively. Subgroup analyses indicated that a multidose regimen of steroids had marked positive effects on the occurrence of laryngeal oedema (0.14; 0.08 to 0.23) and on the rate of subsequent reintubation (0.19; 0.07 to 0.50), with a risk difference of -0.19 (-0.24 to -0.15; 5) and -0.04 (-0.07 to -0.02; 25). In single doses there was only a trend towards benefit, with the confidence interval including 1. Side effects related to steroids were not found. CONCLUSION Prophylactic administration of steroids in multidose regimens before planned extubation reduces the incidence of laryngeal oedema after extubation and the consequent reintubation rate in adults, with few adverse events.
Collapse
Affiliation(s)
- Tao Fan
- Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Roberts RJ, Welch SM, Devlin JW. Corticosteroids for prevention of postextubation laryngeal edema in adults. Ann Pharmacother 2008; 42:686-91. [PMID: 18413685 DOI: 10.1345/aph.1k655] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE To evaluate the efficacy and safety of prophylactic corticosteroid therapy in preventing postextubation laryngeal edema (PELE) and the need for reintubation in adults. DATA SOURCES Literature was accessed through MEDLINE (1966-January 2008) and the Cochrane Library using the terms laryngeal edema, airway obstruction, postextubation stridor, intubation, glucocorticoids, and corticosteroids. Bibliographies of cited references were reviewed and a manual search of abstracts from recent pulmonary and critical care meetings was completed. STUDY SELECTION AND DATA EXTRACTION All English-language, placebo-controlled, randomized studies evaluating the use of prophylactic corticosteroids for the prevention of postextubation laryngeal edema or postextubation stridor (PES) in adults were reviewed. DATA SYNTHESIS Although laryngoscopy is the gold standard method for diagnosing PELE, PES is more commonly used for diagnosis in clinical practice. While 3 older studies failed to demonstrate benefit with the prophylactic administration of corticosteroid therapy in terms of reducing PELE, PES, or the need for reintubation, each of these studies evaluated only a single dose of steroid therapy that was initiated only 30-60 minutes prior to a planned extubation in a population of patients at low-risk for PELE. In comparison, 3 newer studies, each using 4 doses of corticosteroid therapy initiated 12-24 hours prior to a planned extubation in patients deemed to be at high baseline risk for developing PELE, demonstrated a reduction in PELE, PES, and the need for reintubation; no safety concerns were identified. Current evidence therefore suggests that prophylactic intravenous methylprednisolone therapy (20-40 mg every 4-6 h) should be considered 12-24 hours prior to a planned extubation in patients at high-risk for PELE (eg, mechanical ventilation > 6 days). CONCLUSIONS Data from the most recent well-designed clinical trials suggest that prophylactic corticosteroid therapy can reduce the incidence of PELE and the subsequent need for reintubation in mechanically ventilated patients at high-risk for PELE. Based on this information, clinicians should consider initiating prophylactic corticosteroid therapy in this population. Further studies are needed to establish the optimal dosing regimens as well as the subgroups of patients at high risk for PELE who will derive the greatest benefit from this preventive steroid therapy.
Collapse
Affiliation(s)
- Russel J Roberts
- School of Pharmacy, Northeastern University, Boston, MA 02111, USA.
| | | | | |
Collapse
|
15
|
Lee CH, Peng MJ, Wu CL. Dexamethasone to prevent postextubation airway obstruction in adults: a prospective, randomized, double-blind, placebo-controlled study. CRITICAL CARE : THE OFFICIAL JOURNAL OF THE CRITICAL CARE FORUM 2008; 11:R72. [PMID: 17605780 PMCID: PMC2206529 DOI: 10.1186/cc5957] [Citation(s) in RCA: 92] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/31/2007] [Revised: 05/08/2007] [Accepted: 07/02/2007] [Indexed: 11/10/2022]
Abstract
Introduction Prophylactic steroid therapy to reduce the occurrence of postextubation laryngeal edema is controversial. Only a limited number of prospective trials involve adults in an intensive care unit. The purpose of this study was to ascertain whether administration of multiple doses of dexamethasone to critically ill, intubated patients reduces or prevents the occurrence of postextubation airway obstruction. Another specific objective of our study was to investigate whether an after-effect (that is, a transient lingering benefit) exists 24 hours after the discontinuation of dexamethasone. Methods A randomized, placebo-controlled, double-blind trial was conducted in an adult medical intensive care unit of a tertiary care hospital. Eighty-six patients who had been intubated for more than 48 hours with a cuff leak volume (CLV) of less than 110 ml and who met weaning criteria were randomly assigned to receive either dexamethasone (5 mg; n = 43) or placebo (normal saline; n = 43) every six hours for a total of four doses on the day preceding extubation. CLV was measured before the first injection, one hour after each injection, and 24 hours after the fourth injection. Extubation was carried out 24 hours after the last injection. Postextubation obstruction (defined as the presence of stridor) was recorded within 48 hours of extubation. Results Administration of dexamethasone during the 24-hour period preceding extubation resulted in a statistically significant increase in the CLV (p < 0.05). The significant increase of CLV and change of CLV relative to baseline tidal volume (percentage) occurred not only throughout the treatment period, but also 24 hours after the last dexamethasone injection. The incidence of postextubation stridor was significantly lower in the dexamethasone group than in the placebo group (10% [4/40] versus 27.5% [11/40]; p = 0.037), whereas there was no significant difference in reintubation rate between the two groups (2.5% [1/40] versus 5% [2/40]; p = 0.561). Conclusion Prophylactic administration of multiple-dose dexamethasone is effective in reducing the incidence of postextubation stridor in adult patients at high risk for postextubation laryngeal edema. The after-effect of dexamethasone may validate the reduced incidence of postextubation stridor after multiple doses of dexamethasone. Trial registration NCT00452062.
Collapse
Affiliation(s)
- Chao-Hsien Lee
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mackay Memorial Hospital, No. 92, Section 2, Chung Shan North Road, Taipei City 104, Taiwan
| | - Ming-Jen Peng
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mackay Memorial Hospital, No. 92, Section 2, Chung Shan North Road, Taipei City 104, Taiwan
| | - Chien-Liang Wu
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mackay Memorial Hospital, No. 92, Section 2, Chung Shan North Road, Taipei City 104, Taiwan
- Mackay Medicine, Nursing and Management College, No.92, Shengjing Rd., Beitou District, Taipei City 112, Taiwan
| |
Collapse
|
16
|
Morales JL, Krzeminski J, Amin S, Perdew GH. Characterization of the antiallergic drugs 3-[2-(2-phenylethyl) benzoimidazole-4-yl]-3-hydroxypropanoic acid and ethyl 3-hydroxy-3-[2-(2-phenylethyl)benzoimidazol-4-yl]propanoate as full aryl hydrocarbon receptor agonists. Chem Res Toxicol 2008; 21:472-82. [PMID: 18179178 DOI: 10.1021/tx700350v] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates most of the toxic effects of numerous chlorinated (e.g., TCDD) and nonchlorinated polycyclic aromatic compounds (e.g., benzo[ a]pyrene). Studies in AhR null mice suggested that this receptor may also play a role in the modulation of immune responses. Recently, two drugs, namely, M50354 and M50367 (ethyl ester derivative of M50354), were described as AhR ligands with high efficacy toward reducing atopic allergic symptoms in an AhR-dependent manner by skewing T helper cell differentiation toward a T H1 phenotype [Negishi et al. (2005) J. Immunol. 175 (11), 7348-7356]. Surprisingly, these drugs were shown to have minimal activity toward inducing classical dioxin responsive element-driven AhR-mediated CYP1A1 transcription. We synthesized and reevaluated the ability of these drugs to regulate AhR activity. In contrast to previously published data, both M50354 and M50367 were found to be potent inducers of several AhR target genes, namely, CYP1A1, CYP1B1, and UGT1A2. M50367 was a more effective agonist than M50354, perhaps accounting for its higher bioavailability in vivo. However, M50354 was capable of displacing an AhR-specific radioligand more effectively than M50367. This is consistent with M50354 being the active metabolite of M50367. In conclusion, two selective inhibitors of TH2 differentiation are full AhR agonists.
Collapse
Affiliation(s)
- José Luis Morales
- Graduate Program in Biochemistry, Microbiology, and Molecular Biology, Department of Pharmacology, College of Medicine, The Pennsylvania State University, University Park, PA 16802, USA
| | | | | | | |
Collapse
|
17
|
François B, Bellissant E, Gissot V, Desachy A, Normand S, Boulain T, Brenet O, Preux PM, Vignon P. 12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial. Lancet 2007; 369:1083-9. [PMID: 17398307 DOI: 10.1016/s0140-6736(07)60526-1] [Citation(s) in RCA: 132] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND The efficacy of corticosteroids in reducing the incidence of postextubation laryngeal oedema is controversial. We aimed to test our hypothesis that methylprednisolone started 12 h before a planned extubation could prevent postextubation laryngeal oedema. METHODS We did a placebo-controlled, double-blind multicentre trial in 761 adults in intensive-care units. Patients who were ventilated for more than 36 h and underwent a planned extubation received intravenous 20 mg methylprednisolone (n=380) or placebo (381) 12 h before extubation and every 4 h until tube removal. The primary endpoint was occurrence of laryngeal oedema within 24 h of extubation. Laryngeal oedema was clinically diagnosed and deemed serious if tracheal reintubation was needed. Analyses were done on a per protocol and intention-to-treat basis. This trial is registered at ClinicalTrials.gov, number NCT00199576. FINDINGS 63 patients could not be assessed, mainly because of self-extubation (n=16) or cancelled extubation (44) between randomisation and planned extubation. 698 patients were analysed (343 in placebo group, 355 in methylprednisolone group). Methylprednisolone significantly reduced the incidence of postextubation laryngeal oedema (11 of 355, 3%vs 76 of 343, 22%, p<0.0001), the global incidence of reintubations (13 of 355, 4%vs 26 of 343, 8%, p=0.02), and the proportion of reintubations secondary to laryngeal oedema (one of 13, 8 %vs 14 of 26, 54%, p=0.005). One patient in each group died after extubation, and atelectasia occurred in one patient given methylprednisolone. INTERPRETATION Methylprednisolone started 12 h before a planned extubation substantially reduced the incidence of postextubation laryngeal oedema and reintubation. Such pretreatment should be considered in adult patients before a planned extubation that follows a tracheal intubation of more than 36 h.
Collapse
Affiliation(s)
- Bruno François
- Medical-Surgical Intensive Care Unit, Dupuytren Teaching hospital, Limoges, France
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Cheng KC, Hou CC, Huang HC, Lin SC, Zhang H. Intravenous injection of methylprednisolone reduces the incidence of postextubation stridor in intensive care unit patients*. Crit Care Med 2006; 34:1345-50. [PMID: 16540947 DOI: 10.1097/01.ccm.0000214678.92134.bd] [Citation(s) in RCA: 100] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To determine whether treatment with corticosteroids decreases the incidence of postextubation airway obstruction in an adult intensive care unit. DESIGN Clinical experiment. SETTING Adult medical and surgical intensive care unit of a teaching hospital. PATIENTS One hundred twenty-eight patients who were intubated for >24 hrs with a cuff leak volume <24% of tidal volume and met weaning criteria. INTERVENTIONS : Patients were randomized into a placebo group (control, n = 43) receiving four injections of normal saline every 6 hrs, a 4INJ group (n = 42) receiving four injections of methylprednisolone sodium succinate, or a 1INJ group (n = 42) receiving one injection of the corticosteroid followed by three injections of normal saline. Cuff volume was assessed 1 hr after each injection, and extubation was performed 1 hr after the last injection. Postextubation stridor was confirmed by examination using bronchoscopy or laryngoscopy. MEASUREMENTS AND MAIN RESULTS The incidences of postextubation stridor were lower both in the 1INJ and the 4INJ groups than in the control group (11.6% and 7.1% vs. 30.2%, both p < .05), whereas there was no difference between the two treated groups (p = .46). The cuff leak volume increased after the second and fourth injection in the 4INJ group and after a second injection in the 1INJ group compared with the control group (both p < .05). CONCLUSIONS A reduced cuff leak volume is a reliable indicator to identify patients at high risk to develop stridor. Treatment with a single or multiple injections of methylprednisolone can effectively reduce the occurrence of postextubation stridor.
Collapse
Affiliation(s)
- Kuo-Chen Cheng
- Department of Intensive Care Medicine, Chi Mei Medical Center, Tainan, Taiwan
| | | | | | | | | |
Collapse
|
19
|
Chin KJ, Chee VWT. Laryngeal edema associated with the ProSeal laryngeal mask airway in upper respiratory tract infection. Can J Anaesth 2006; 53:389-92. [PMID: 16575039 DOI: 10.1007/bf03022505] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
Abstract
PURPOSE We report an unusual case of vocal cord edema associated with the use of a ProSeal laryngeal mask airway (PLMA) in an adult patient with an undiagnosed upper respiratory tract infection (URTI). CLINICAL FEATURES A 55-yr-old woman had fixation of a radial fracture under general anesthesia with muscle relaxation. She developed audible wheezing 30 min after PLMA insertion. Bronchoscopic examination revealed significant vocal cord edema. Adequate ventilation was possible at increased airway pressures, and the administration of dexamethasone 4 mg iv produced clinical resolution of the stridor and airway obstruction. The patient admitted to having mild symptoms of an URTI on postoperative questioning. CONCLUSION Airway hyperreactivity secondary to the URTI is the most likely etiological factor; other possibilities include trauma from insertion and chemical irritation. Although pediatric studies suggest that the LMA-Classic carries less risk than endotracheal intubation in the presence of URTI, this case report demonstrates that caution is still warranted when using supraglottic airways. The PLMA permitted effective ventilation despite increased airway resistance; nevertheless its role in patients with URTI is unclear. It is possible that the bulkier cuff design of the PLMA, compared to that of the LMA-Classic, may have partly contributed to the development of edema in this setting.
Collapse
Affiliation(s)
- Ki Jinn Chin
- Department of Anesthesiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Republic of Singapore.
| | | |
Collapse
|
20
|
Potsic WP, Wetmore RF. Otolaryngologic Disorders. PEDIATRIC SURGERY 2006. [PMCID: PMC7158348 DOI: 10.1016/b978-0-323-02842-4.50055-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
21
|
Abstract
The perioperative risk for patients with obstructive sleep apnea syndrome and the optimal anaesthesiological management of these patients have not been well elucidated. The prevalence of obstructive sleep apnea with significant symptoms is estimated to be 4% in men and 2% in women. However, in 80-95% of patients this syndrome is not sufficiently diagnosed. Thus identification of patients at risk and a thorough multidisciplinary diagnostic approach are essential for optimal perioperative management. The risk of perioperative complications, like cardiopulmonary compromise, and difficulties in airway management is elevated. The most important aspects of perioperative management include evaluation of intubating conditions, careful search for cardiopulmonary morbidity, permanent control of patient airways, sensible use of anaesthetics, sedatives, and narcotics, and strict monitoring of vital signs. If ambulatory nasal continuous positive airway pressure (CPAP) therapy has been established preoperatively, this should be continued in the perioperative period. Postoperative monitoring should be performed in an intensive care or intermediate care unit. Controlled clinical studies on the best perioperative management of patients with obstructive sleep apnea are urgently required.
Collapse
Affiliation(s)
- B Hartmann
- Abteilung Anaesthesiologie, Intensivmedizin, Schmerztherapie, Universitätsklinikum Giessen
| | | | | |
Collapse
|
22
|
Holden JP, Vaughan WC, Brock-Utne JG. Airway complication following functional endoscopic sinus surgery. J Clin Anesth 2002; 14:154-7. [PMID: 11943532 DOI: 10.1016/s0952-8180(01)00376-2] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Difficulty breathing after upper airway surgery requires immediate evaluation and treatment. We present a case of airway compromise after sinus surgery due to edema of the uvula. The patient was admitted for observation overnight and discharged the next day. A discussion of potential airway changes after sinonasal surgery is presented.
Collapse
Affiliation(s)
- Jeffrey P Holden
- Department of Anesthesia, Stanford University School of Medicine, CA 94305-5640, USA
| | | | | |
Collapse
|
23
|
Pappas AL, Sukhani R, Hotaling AJ, Mikat-Stevens M, Javorski JJ, Donzelli J, Shenoy K. The effect of preoperative dexamethasone on the immediate and delayed postoperative morbidity in children undergoing adenotonsillectomy. Anesth Analg 1998; 87:57-61. [PMID: 9661546 DOI: 10.1097/00000539-199807000-00013] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
UNLABELLED In this prospective, randomized, double-blind, placebo-controlled study, we examined the effect of preoperative dexamethasone on postoperative nausea and vomiting (PONV) and 24-h recovery in children undergoing tonsillectomy. One hundred thirty children, 2-12 yr of age, ASA physical status I or II, completed the study. All children received oral midazolam 0.5-0.6 mg/kg preoperatively. Anesthesia was induced with halothane and nitrous oxide in 60% oxygen and maintained with nitrous oxide and isoflurane. Intubation was facilitated by mivacurium 0.2 mg/kg. Each child received fentanyl 1 microgram/kg i.v. before initiation of surgery, as well as dexamethasone 1 mg/kg (maximal dose 25 mg) (steroid group) or an equal volume of saline (control group). Intraoperative fluids were standardized to 25-30 mL/kg lactated Ringer's solution. All tonsillectomies were performed under the supervision of one attending surgeon using an electrodissection technique. Postoperatively, fentanyl and acetaminophen with codeine elixir were administered as needed for pain. Rescue antiemetics were administered when a child experienced two episodes of retching and/or vomiting. Before home discharge, the incidence of PONV, need for rescue antiemetics, quality or oral intake, and analgesic requirements did not differ between groups. However, during the 24 h after discharge, more patients in the control group experienced PONV (62% vs 24% in the steroid group) and complained of poor oral intake. Additionally, more children in the control group (8% vs 0% in the steroid group) returned to the hospital for the management of PONV and/or poor oral intake. The preoperative administration of dexamethasone significantly decreased the incidence of PONV over the 24 h after home discharge in these children. IMPLICATIONS In this double blind, placebo-controlled study, we examined the efficacy of a single large dose (1 mg/kg; maximal dose 25 mg) of preoperative dexamethasone on posttonsillectomy postoperative nausea and vomiting (PONV) in children 2-12 yr of age undergoing tonsillectomy. Compared with placebo, dexamethasone significantly decreased the incidence of PONV in the 24 h after discharge, improved oral intake, decreased the frequency of parental phone calls, and resulted in no hospital returns for the management of PONV and/or poor oral intake.
Collapse
Affiliation(s)
- A L Pappas
- Department of Anesthesiology, Loyola University Medical Center, Maywood, Illinois 60153, USA
| | | | | | | | | | | | | |
Collapse
|
24
|
Pappas ALS, Sukhani R, Hotaling AJ, Mikat-Stevens M, Javorski JJ, Donzelli J, Shenoy K. The Effect of Preoperative Dexamethasone on the Immediate and Delayed Postoperative Morbidity in Children Undergoing Adenotonsillectomy. Anesth Analg 1998. [DOI: 10.1213/00000539-199807000-00013] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
25
|
Ho LI, Harn HJ, Lien TC, Hu PY, Wang JH. Postextubation laryngeal edema in adults. Risk factor evaluation and prevention by hydrocortisone. Intensive Care Med 1996; 22:933-6. [PMID: 8905428 DOI: 10.1007/bf02044118] [Citation(s) in RCA: 79] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVE To evaluate the risk factors for postextubation laryngeal stridor and its prevention by hydrocortisone in adult patients. DESIGN Prospective, randomized, double-blind, placebo controlled study. SETTING Medical and surgical ICU of a tertiary teaching hospital. PATIENTS 77 consecutive patients of both sexes, who had undergone tracheal intubation for more than 24 h and fulfilled the weaning criteria, were eligible for the study. Patients were excluded if they were less than 15 years of age, had a disease or the surgery of the throat, or had been extubated during the current hospitalization. INTERVENTION The control group received placebo (normal saline 3 cc) and the experimental group received hydrocortisone 100 mg by intravenous infusion 60 min before extubation. MAIN OUTCOME MEASURES Patients were observed 24 h after extubation for symptoms or signs of laryngeal edema or stridor: prolonged inspiration with accessory usage of respiratory muscles or crowing sound with inspiration or reintubation. RESULTS The overall incidence of postextubation stridor was 22% (17/77). Only one patient (1%), who belonged to the control group, needed reintubation. 39% of female patients and 17% of male patients developed stridor. The relative risk of females developing this complication was 2.29. 7/39 of the hydrocortisone group and 10/38 of patients in the control group developed postextubation stridor. CONCLUSIONS Hydrocortisone did not significantly reduce the incidence of postextubation laryngeal edema or stridor. From the risk factors evaluated, we were unable to demonstrate a statistical correlation between postextubation stidor and the duration of the intubation, the patient's age, the internal diameter of the endotracheal tube, or the route of intubation. However, female patients were more likely to develop this complication.
Collapse
Affiliation(s)
- L I Ho
- Department of Respiratory Therapy, Veterans General Hospital-Taipei, Taiwan, R.O.C
| | | | | | | | | |
Collapse
|
26
|
Mallat A, Roberson J, Brock-Utne JG. Preoperative marijuana inhalation--an airway concern. Can J Anaesth 1996; 43:691-3. [PMID: 8807175 DOI: 10.1007/bf03017953] [Citation(s) in RCA: 53] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
PURPOSE Cannabis Sativa (marijuana) may cause a variety of respiratory disorders including uvular oedema. This case illustrates that uvular oedema secondary to marijuana inhalation may cause a potentially serious postoperative clinical problem. CLINICAL FEATURES A healthy 17-yr-old man who inhaled marijuana prior to general anaesthesia. In the recovery room, after an uneventful general anaesthetic, acute uvular oedema resulted in post operative airway obstruction and admission to hospital. The uvular oedema was treated successfully with dexamethasone. CONCLUSION Recent inhalation of marijuana before general anaesthesia may cause acute uvular oedema and post operative airway obstruction. The uvular oedema can be easily diagnosed and treated.
Collapse
Affiliation(s)
- A Mallat
- Anesthesia Department, Stanford University Medical Center, CA 94305-5115, USA
| | | | | |
Collapse
|
27
|
Volk MS, Martin P, Brodsky L, Stanievich JF, Ballou M. The effects of preoperative steroids on tonsillectomy patients. Otolaryngol Head Neck Surg 1993; 109:726-30. [PMID: 8233511 DOI: 10.1177/019459989310900415] [Citation(s) in RCA: 57] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
A prospective, randomized, double-blind study to determine the postoperative efficacy of steroids in tonsillectomy was performed in 49 children. A single dose of intravenous dexamethasone or placebo was administered after each child was anesthetized. Postoperatively each child was examined for objective signs of trismus (measured by interincisor distance), temperature elevation, and weight loss, as well as for subjective signs of mouth odor, oral intake, pain, level of activity, and analgesic usage. There were no statistical differences noted in any of the variables compared in the two groups and the complication rates were also similar.
Collapse
Affiliation(s)
- M S Volk
- Department of Otolaryngology, State University of New York at Buffalo
| | | | | | | | | |
Collapse
|
28
|
Chaturvedi VN, Chaturvedi P. Acute laryngeal stridor--controversies in current management. Indian J Pediatr 1992; 59:593-9. [PMID: 1459682 DOI: 10.1007/bf02832997] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
- V N Chaturvedi
- Department of Otorhinolaryngology M. G. Institute of Medical Sciences, Sevagram
| | | |
Collapse
|
29
|
Tellez DW, Galvis AG, Storgion SA, Amer HN, Hoseyni M, Deakers TW. Dexamethasone in the prevention of postextubation stridor in children. J Pediatr 1991; 118:289-94. [PMID: 1993963 DOI: 10.1016/s0022-3476(05)80505-0] [Citation(s) in RCA: 88] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
To assess whether there is any advantage in the use of corticosteroid to prevent postextubation stridor in children, we conducted a prospective, randomized, double-blind trial of dexamethasone versus saline solution. The patients were evaluated and then randomly selected to receive either dexamethasone or saline solution according to a stratification based on risk factors for postextubation stridor: age, duration of intubation, upper airway trauma, circulatory compromise, and tracheitis. Dexamethasone, 0.5 mg/kg, was given every 6 hours for a total of six doses beginning 6 to 12 hours before and continuing after endotracheal extubation in a pediatric intensive care setting. There was no statistical difference in incidence of postextubation stridor in the two groups; 23 of 77 children in the placebo group and 16 of 76 in the dexamethasone group had stridor requiring therapy (p = 0.21). We conclude that the routine use of corticosteroids for the prevention of postextubation stridor during uncomplicated pediatric intensive care airway management is unwarranted.
Collapse
Affiliation(s)
- D W Tellez
- Division of Pediatric Intensive Care, Childrens Hospital Los Angeles, CA 90027
| | | | | | | | | | | |
Collapse
|
30
|
Barrett AP. Dexamethasone as an adjunct in oropharyngeal obstruction in a patient with leukemia. ORAL SURGERY, ORAL MEDICINE, AND ORAL PATHOLOGY 1990; 70:741-3. [PMID: 2263333 DOI: 10.1016/0030-4220(90)90012-h] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Incipient airway obstruction due to fulminating bacterial infection of pharyngeal tissues requires prompt and definitive intervention. A case is presented in which dexamethasone was a key adjunct to antibiotic therapy in averting this problem in a severely neutropenic patient with acute leukemia.
Collapse
Affiliation(s)
- A P Barrett
- Department of Medicine, Westmead Hospital, New South Wales, Australia
| |
Collapse
|
31
|
Abstract
Differentiating upper- from lower-airway compromise in the neonate may be difficult. Knowledge of the multiple problems that affect the airway and an organized approach to assessment aid in determining the site(s) of respiratory compromise. Although endoscopy provides information about the status of the upper airway, the length of time elapsed from extubation may affect the predictive value of observations made at endoscopy. The otolaryngologist should avoid recommending surgical intervention for relief of upper-airway compromise when the major cause of respiratory insufficiency is in the lower airway. Conversely, appropriate surgical intervention at the appropriate time may obviate the need for a tracheotomy. Lastly, if the prognosis is such that continued intubation is necessary and may lead to laryngeal or subglottic damage, a tracheotomy should be performed.
Collapse
|
32
|
Woods CI, Postma DS, Prazma J, Sidman J. Effects of Dexamethasone and Oxymetazoline on “Postintubation Croup”: A ferret model. Otolaryngol Head Neck Surg 1987. [DOI: 10.1177/019459988709600606] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Several studies recommend the use of steroids and racemic epinephrine for treatment of postintubation croup. Few controlled clinical or laboratory studies, however, support their effectiveness, and many questions remain about their use. The present study was undertaken to develop a reproducible animal model for postintubation croup and to perform initial controlled studies of the effects of dexamethasone (4 mg/kg) and the long-acting vasoconstrictor oxymetazoline (0.01 solution). An animal model for intubation trauma was developed with ten 10-week-old ferrets. Two models were created to reflect the spectrum of trauma—from simple mucosal contusion to mucosal ulceration. The first was to surgically strip mucosa in a circumferential manner at the level of the cricoid ring; the second was intubation trauma to the glottic and subglottic regions by use of a circular brush. Neither dexamethasone nor oxymetazoline had any statistically significant effect on subglottic edema in the mucosal stripping model. In the brush intubation model, oxymetazoline decreased subglottic edema at 2, 4, and 8 hours ( P < 0.05), while dexamethasone and combination therapy decreased edema at 2,4, 8, and 24 hours ( P < 0.05). At 24 hours, combination therapy was demonstrated to be the most effective in reducing subglottic edema. Oxymetazoline was as effective as dexamethasone and combination therapy at 2, 4, and 8 hours ( P < 0.05). In this preliminary study, we have established the potential usefulness of the brush intubation model for the study of this disorder. This model was shown to have a reproducible and reversible lesion. The mucosal stripping model was not shown to have reversible lesion and—while further study needs to be performed—may only be useful as a model for very severe cases of this disorder. These initial studies also demonstrated high-dose dexamethasone and oxymetazoline to be effective in treatment of subglottic edema secondary to mucosal trauma. They also indicate that combination therapy is a more effective treatment than either agent alone.
Collapse
Affiliation(s)
- Charles I. Woods
- Chapel Hill, North Carolina
- From the Division of Otolaryngology, University of North Carolina School of Medicine
| | - Duncan S. Postma
- Chapel Hill, North Carolina
- From the Division of Otolaryngology, University of North Carolina School of Medicine
| | - Jiri Prazma
- Chapel Hill, North Carolina
- From the Division of Otolaryngology, University of North Carolina School of Medicine
| | - James Sidman
- Chapel Hill, North Carolina
- From the Division of Otolaryngology, University of North Carolina School of Medicine
| |
Collapse
|
33
|
Use of a carbon dioxide laser for treatment of recurrent laryngeal papillomatosis in small children: Experiences with an anaesthetic technique. Lasers Med Sci 1986. [DOI: 10.1007/bf02040241] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Abstract
Infectious croup is a viral or bacterial syndrome characterized by a barking cough, hoarseness, and stridor. Three separate conditions will be discussed: laryngotracheobronchitis, spasmotic croup, and bacterial tracheitis. Each clinical entity will be defined and its treatment reviewed. Current treatment regimens for infectious croup involve various combinations of mist therapy, racemic epinephrine, corticosteroids, and syrup of ipecac. Tradition, rather than science, appears to be the basis of many of these treatments. Despite the frequent occurrence of infectious croup, no treatment has proved consistently successful. Prevention and better treatment methods are the keys for reducing the high cost of infectious croup to the medical care system.
Collapse
|
35
|
Pransky SM, Grundfast KM. Differentiating upper from lower airway compromise in neonates. Ann Otol Rhinol Laryngol 1985; 94:509-15. [PMID: 4051409 DOI: 10.1177/000348948509400520] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Technologic advancements and improvements in supportive care have resulted in increased survival of very low birth weight and premature infants. With salvage of these high risk newborns, many difficult management problems arise. Respiratory distress of the newborn is the most common airway problem that affects these patients and subglottic edema or stenosis may frequently complicate management of the airway. Decision-making in airway maintenance and respiratory care can be problematic due to multiple factors that must be considered. The otolaryngologist is often consulted when upper airway obstruction is suspected. Relevant respiratory physiology is reviewed in order to help direct therapeutic decision-making. Parameters of assessment are enumerated and methods for choosing among therapeutic alternatives are presented. A paradigm to aid in differential diagnosis is described.
Collapse
|